Anna R. Panchenko
Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (5)
Year:
2026
Cancer can develop through the accumulation of somatic mutations that drive uncontrolled cell proliferation. A central objective in cancer research is to identify mutations that provide a selective growth advantage to tumor cells, so‐called driver mutations. Many computational methods infer driver missense mutations in proteins by assessing their recurrence. However, such an approach suffers from the limited capacity to detect those driver mutations that occur infrequently across tumor samples. One strategy to overcome this limitation is to aggregate mutations from proteins sharing the same protein domain. Here we constructed a benchmark of cancer driver and passenger mutations, based on the known experimental and clinical studies, and systematically evaluated the applicability of methods that aggregate mutations across different mutation types and protein domains. We found that accounting for evidence mutations from different types of amino acid substitutions occurring in the same protein position enhances the classification performance. Furthermore, accounting for evidence mutations from paralogous proteins in the domain family increased the precision but compromised the overall classification accuracy. In addition, the performance of domain‐based approaches was shown to crucially depend on the similarity between the target and evidence proteins.
Year:
2026
Nucleosomes serve as fundamental units of chromatin packaging and play a crucial role as central hubs in epigenetic regulation. Their positions throughout the genome are not random and follow certain patterns, influenced by DNA sequence, histone‐DNA interactions, chromatin physical barriers, nucleosome sliding and unwrapping, and chromatin modifications. There are many experimental techniques for identifying nucleosome positions, but these methods often involve a trade‐off between achieving high resolution and covering the entire genome. In this regard, computational approaches may offer a fast alternative, with the benefit of aiding experimental analysis by denoising data, refining nucleosome boundaries, and identifying features critical for nucleosome positioning. Moreover, computational predictions enable the integration of nucleosome positioning data with other genomic and epigenomic datasets, providing a more comprehensive view of chromatin organization and gene regulation. In this review, we focus on various nucleosome positioning methods, including experimental techniques of nucleosome boundaries identification and in silico methods of nucleosome positioning data denoising and prediction of nucleosome positioning from the DNA sequence.
Year:
2025
Cancer can develop through the accumulation of somatic mutations that drive uncontrolled cell proliferation. A central objective in cancer research is to identify mutations that provide a selective growth advantage to tumor cells, so called driver mutations. Many computational methods infer driver missense mutations in proteins by assessing their recurrence. However, such approach suffers from the limited capacity to detect those driver mutations that occur infrequently across tumor samples. One strategy to overcome this limitation is to aggregate mutations from proteins sharing the same protein domain. Here we constructed a benchmark of cancer driver and passenger mutations, based on the known experimental and clinical studies, and systematically evaluated the applicability of methods that aggregate mutations across different mutation types and protein domains. We found that accounting for evidence mutations from different types of amino acid substitutions occurring in the same protein position enhances the classification performance. Furthermore, accounting for evidence mutations from paralogous proteins in the domain family increased the precision but compromised the overall classification accuracy. In addition, the performance of domain-based approaches was shown to crucially depend on the similarity between the target and evidence proteins.
Year:
2025
Histones play a critical role in chromatin function but are susceptible to mutagenesis. In fact, numerous mutations have been observed in several cancer types, and a few of them have been associated with carcinogenesis. Histones are peculiar, as they are encoded by a large number of genes, and the majority of them are clustered in three regions of the human genome. In addition, their replication and expression are tightly regulated in a cell. Understanding the etiology of cancer mutations in histone genes is impeded by their functional and sequence redundancy, their unusual genomic organization, and the necessity to be rapidly produced during cell division. Here, we collected a large data set of histone gene mutations in cancer and used it to investigate their distribution over 96 human histone genes and 68 different cancer types. This analysis allowed us to delineate the factors influencing the probability of mutation accumulation in histone genes and to detect new histone gene drivers. Although no significant difference in observed mutation rates between different histone types was detected for the majority of cancer types, several cancers demonstrated an excess or depletion of mutations in histone genes. As a consequence, we identified seven new histone genes as potential cancer-specific drivers. Interestingly, mutations were found to be distributed unevenly in several histone genes encoding the same protein, pointing to different factors at play, which are specific to histone function and genomic organization. Our study also elucidated mutational processes operating in genomic regions harboring histone genes, highlighting POLE as a factor of potential interest.
Year:
2023
Collaborators (1)
Maria Aristizabal
Assistant Professor
Queen's University
Make your next move.
Prepare your application
Review drafts before you send them.